Harnessing bacterial endophytome to manage fusarium wilt of banana

Overview

Banana production worldwide faces a critical threat from Fusarium wilt caused by Fusarium oxysporum f. sp. cubense (FOC), particularly Tropical Race 4 (TR4). While resistant banana genotypes exist, they lack commercial appeal because consumers do not prefer them. This solution addresses that gap by isolating and harnessing beneficial bacterial endophytes from resistant genotypes and applying them to high-yielding, commercially preferred but susceptible cultivars through bio-hardening of tissue culture plants and rhizosphere engineering.

The approach is grounded in MAMP (Microbe-Associated Molecular Pattern) triggered immunity, which activates the plant's natural defense responses. The bacterial endophytes produce secondary metabolites and antimicrobial peptides with broad-spectrum antifungal activity against multiple FOC races, offering a biocontrol strategy that also enhances soil health and crop yield.

Technical specifications

Key features:

• Isolation of unique bacterial endophytes from FOC-resistant banana genotypes, representing diverse genera not found in susceptible cultivars
• Bio-hardening of tissue culture banana plants using effective bacterial antagonists such as Bacillus velezensis to induce systemic resistance
• Rhizosphere drenching with selected bacterial strains to suppress FOC in the root zone
• Production of broad-spectrum antifungal biomolecules including clidamycin, hydroxy methyl furfural, glafenine hydrochloride, 2,4-di-tert-butyl phenol, and antimicrobial peptides
• MAMP-triggered immunity induction against FOC races, with particular efficacy against FOC TR4
• Dual benefit of disease suppression and yield improvement under field conditions

Research and development pipeline:

• Whole genome sequencing of effective bacterial antagonists
• Transcriptome profiling of banana cultivars challenged with FOC TR4 in the presence and absence of bacterial antagonists
• Analysis of defense gene transcripts and transcription factor expression
• Molecular docking and simulation of protein-protein interactions between bacterial biomolecules and pathogen virulence factors
• Development of SCAR markers for effective bacterial strains
• Formulation development including nano-formulations, water-soluble tablets, and liquid formulations with enhanced cell counts
• Field validation of formulations in FOC-endemic areas

Technology readiness level

The technology has reached proof-of-concept stage with published validation. Research published in Environmental Microbiology (Saravanan and Nakkeeran, 2022) demonstrated that unique bacterial endophytes from resistant genotypes produce antifungal secondary metabolites capable of inducing resistance and suppressing FOC. Field trials have confirmed that application of Bacillus velezensis through bio-hardening and rhizosphere drenching increases banana yield under FOC pressure.

Future validation efforts include genomic characterization, transcriptome analysis, formulation development, and field validation in endemic areas to advance the technology toward commercial readiness.